Male Breast Carcinoma Terminated Phase 1 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01149356RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerTreatment